Acromegaly and breast cancer risk: evidence from a systematic review and meta-analysis.

Front Endocrinol (Lausanne) · 2025 · PMC12640837 · PMID 41293738

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The combined SIR was 1.20 (95% CI, 0.94–1.54), suggesting a possible increase in breast cancer risk among patients with acromegaly, although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.